Literature DB >> 21814390

Structure-Activity relationship in mutated pyrazinamidases from Mycobacterium tuberculosis.

Miguel Quiliano, Andres Hazaet Gutierrez, Robert Hugh Gilman, César López, Wilfredo Evangelista, Jun Sotelo, Patricia Sheen, Mirko Zimic.   

Abstract

The pncA gene codes the pyrazinamidase of Mycobacterium tuberculosis, which converts pyrazinamide to ammonia and pyrazinoic-acid, the active antituberculous compound. Pyrazinamidase mutations are associated to pyrazinamide-resistant phenotype, however how mutations affect the structure of the pyrazinamidase, and how structural changes affect the enzymatic function and the level of pyrazinamide-resistance is unknown. The structures of mutated pyrazinamidases from twelve Mycobacterium tuberculosis strains and the pyrazinamide-susceptible H37Rv reference strain were modelled using homology modelling and single amino acid replacement. Physical-chemical and structural parameters of each pyrazinamidase were calculated. These parameters were: The change of electrical charge of the mutated amino acid, the change of volume of the mutated amino acid, the change of a special amino acid, the distance of the mutated amino acid to the active site, the distance of the mutated amino acid to the metal-coordination site, and the orientation of the side-chain of the mutated amino acid. The variability of the enzymatic activity of the recombinant pyrazinamidases, and the microbiological susceptibility to pyrazinamide determined by BACTEC 460TB, were modelled in multiple linear regressions. Physical-chemical and structural parameters of the mutated pyrazinamidases were tested as predictors. Structural and physical-chemical variations of the pyrazinamidase explained 75% of the variability of the enzymatic activity, 87% of the variability of the kinetic constant and 40% of the variability of the pyrazinamide-resistance level. Based on computer models of mutated pyrazinamidases, the structural parameters explained a high variability of the enzymatic function, and to a lesser extent the resistance level.

Entities:  

Year:  2011        PMID: 21814390      PMCID: PMC3143395          DOI: 10.6026/97320630006335

Source DB:  PubMed          Journal:  Bioinformation        ISSN: 0973-2063


Background

According to WHO, tuberculosis disease due to Mycobacterium tuberculosis infection caused an estimated 1.3 million deaths, globally. Pyrazinamide (PZA) is an important first-line drug for tuberculosis (TB) and appears to be the most important drug killing M. tuberculosis in its latent stage [1-3]. The concomitant emergence of strains resistant to PZA represents an important public health problem as the efficacy of primary and standardized re-treatment regimens may be inadequate. PZA-susceptible strains possess a pyrazinamidase (PZAse) that converts PZA to ammonia and pyrazinoic acid (POA). POA is the active compound and is transported outside the Mycobacterium by an efflux pump. If the extracellular environment is acid, POA is protonated, returns to Mycobacterium by passive diffusion, and releases the proton. The acidification of the intracellular environment together with the accumulation of intracellular POA lethally alters the membrane permeability [4]. The major mechanism of PZA-resistance is considered to be the loss of PZAse activity linked to mutations in the pncA, the PZAse coding gene. Previous studies showed that mutations in recombinant PZAses decreased the enzymatic activity in about 10 fold, according to the localization of the mutation and the type of substitution [5, 6]. In addition, mutations in PZAses have been shown to generate clinical resistance to PZA [7-9]. The causal pathway that links pncA mutations with PZA resistance should be: [pncA mutations] → [PZAse structural change] → [PZAse functional change] → [PZA resistance level] → [“yes/no” PZAresistant phenotype]. In order to understand how pncA mutations affect the enzymatic function, it is necessary to analyse the three-dimensional structure of mutated PZAses. Previous studies determined structural models of M. tuberculosis PZAse for the PZA-resistant reference strain H37Rv. In these studies the PZAse structure was determined by homology modelling based on the crystallized structures of the homologues Arthrobacter Ncarbamoylsarcosine aminohydrolase (CHSase) [5] and Pyrococcus horikoshii PZAse [10, 11]. Theoretical structural models serve as good approaches when experimental structure data are not available [12]. In a recent study, the PZAse structure of the M. tuberculosis H37Rv strain was resolved by crystallography [13], showing that the structure of PZAses are highly conserved among these species. The critical residues associated with PZAse function are those of the active site (D8, A134, C138) and the metal-binding site (D49, H51, H57, and H71). Mutations in these residues and in residues in close proximity to these sites highly affect the PZAse function [6, 11]. In the present work, we studied the relationship between structural and physical-chemical characteristics of mutated PZAses with the enzymatic function and PZA-resistance level of M. tuberculosis strains.

Methodology

PZAse selection

In a previous work, the PZAse of the H37Rv strain and 12 mutated PZAses (D12G, D12A, G24D, Y34D, K48T, D49N, H51R, T76P, G78C, F94L, L116P, and T135P), from M. tuberculosis PZA-resistant strains were cloned, expressed, and purified. The catalytic constant k, and the enzymatic activity were measured for each recombinant enzyme. The PZA-MIC and the growthindex in BACTEC-460TB at 100 µg/mL PZA were measured for each strain [6]. Data of PZAse function and PZA-resistance is shown in the Table 4 (see Table 4).

Modelling

Theoretical structures were obtained by homology modelling and single amino acid replacement. For each PZAse, two theoretical structures were generated. The first set of structures was obtained by single amino acid replacement using as template the crystal structure of the M. tuberculosis H37Rv PZAse (PDB 3pl1). The second set was obtained by homology modelling using as template the P. horikoshii PZAse crystal structure (PDB 1im5). Modelled structures were refined by energy minimization and molecular dynamics. Energy minimization was performed with GROMACS [14], using the steepest-descent algorithm with a convergence gradient of 10 KJ×mol­1×nm­1. Structures were solvated in explicit water followed by 1ns molecular dynamics (MD) using GROMACS. The accuracy of the models were evaluated using PROCHECK [15].

Physical-chemical and structural parameters

Parameters estimated for the mutated aminoacid included: (1) change of electrical charge; (2) change of volume; (3) change of a special aminoacid; (4) closeness to the active site; (5) closeness to the metal coordination site (MCS); and (6) orientation of the side chain (Tables 1 & 2, see Tables 1 & 2). Aminoacids were considered as: hydrophilic (Basic: K, R and H; Acidic: D and E; and polar with uncharged side-chain group: S, T, N and Q), hydrophobic (A, V, I, L, M, F, Y and W) and special (C, G and P). The volume change was calculated using Pontius values [16]. The closeness of the mutated aminoacid to the active-site and to the MCS, was measured as the distance between the alpha-carbon of the mutated aminoacid and the alpha-carbons of the 3 residues of the active-site (D8, A134, C138) and 3 residues of the MCS (D49, H51, H71). In order to prevent a bias due to over-modelling, amino acid H57 was not considered because its orientation and position in an external loop, showed a low structural stability during the MD run. The distance between the barycentre of the 3 alpha-carbons of the active-site residues and the alpha-carbon of the mutated aminoacid (D_AS) was determined. Similarly, the equivalent distance to the MCS (D_MCS) was also determined. The orientation of the side-chain of the mutated aminoacid was determined by the distance between the barycentre of the 3 alpha-carbons of the active-site residues and the intersection of the projection of the mutated side-chain with the plane defined by the alpha-carbons of the active-site (d_AS). The projection of the side-chain was defined as the resultant vector connecting the alphacarbon with each of the atoms of the side-chain. Similarly, we calculated the equivalent distance for the MCS (d_MCS). We calculated the angle between the projection of the mutated side-chain and the normal vector of the plane defined by the alpha-carbons of the active site (α_AS). We calculated the equivalent angle to the plane defined by the alpha-carbons of the MCS (α_MCS). The orientation of the side-chain of the mutated aminoacid was classified accordingly to whether its projection crosses the triangle formed by the 3 alpha-carbons of the active-site (AS_triangle), and to whether its projection aims at the plane defined by the alpha-carbons of the active-site (AS_plane). We classified the orientation of the side-chain of the mutated amino acid against the MCS triangle (MCS_triangle), and the MCS plane (MCS_plane).

Prediction of PZAse-function and PZA-susceptibility

The variability of the growing-index in BACTEC, the enzymatic activity and k were modelled in a linear regression. The structural and physical-chemical parameters were tested as predictors. The PZA-MIC was also tested as a dichotomous variable: Low-MIC (MIC< 400µg PZA/mL) versus high-MIC (MIC>=400µg PZA/mL). The variability of PZA-MIC was modelled in a logistic regression.

Discussion

This study presents the relationship of theoretical structure models of M. tuberculosis mutated PZAses with a single amino acid substitution with PZAse enzymatic-function and strain PZA-susceptibility. The structural alignment between P. horikoshii and H37Rv M. tuberculosis crystallized PZAses, shows that both structures are highly conserved (RMSD=0.661 A at backbone level). The MCS for H37Rv M. tuberculosis PZAse is proposed to be composed by residues D49, H51, H57, and H71 [13] in contrast to the corresponding of P. horikoshii that lacks H57 [6, 11]. H57 in M. tuberculosis PZAse is located in a loop, which shows structural instability as detected by the MD simulation. To prevent any bias during MD simulation, we obviate the H57 for the extraction of structural parameters. After excluding the H57-loop-region, the two predicted structures of each mutated PZAse were highly similar (RMSD = 0.5 A at backbone level). All results described below were similar for the two models. The major structural changes of the mutated PZAses were in the orientation of the amino acid side-chains and in a lesser extent the backbone. The structural and physical-chemical parameters were able to explain a high variability of the PZAse function and in a lesser extent the variability of the PZA-resistance level. The physical-chemical and structural parameters for the 12 mutated PZAses are shown in Tables 1 & 2 (see Tables 1 & 2). In the univariate analysis, the enzymatic activity, the k, and the Bactec growing index were significantly associated with several structural parameters (Table 3, see Table 3). After adjustment, the best multiple linear model to explain the enzymatic activity included the distance d_MCS (P=0.005) with a determination coefficient R2 of 0.76. The best multiple linear model for the catalytic constant k included the change of electrical charge (P=0.001), the distance d_A134 (P=0.003), the angle α_MCS (P=0.05), and the indicator variable AS_plane (P=0.024), with a determination coefficient R2 of 0.88. The variability of the growing index in BACTEC was significantly associated with the angle α_MCS (P=0.027) with a determination coefficient R2 of 0.40. The change of electrical charge was the dominant term in the models. Therefore, the most important structural parameters able to explain the variability of the PZAse activity and k were related to the physical-chemistry properties of the active site and the MCS. The closeness of the mutation to A134 as a predictor confirms the importance of the active site in the hydrolysis of PZA. As described by Du et al. (2001) the initial interaction of PZA with the PZAse active site at the beginning of the hydrolysis occurs very close to A134 [11]. The closeness of the mutation and the orientation of the mutated amino acid side chain towards the MCS, confirm the importance of the MCS in the hydrolysis of PZA, and explain the high MIC observed in mutations that are close to the MCS and their side chains aim directly at it. Lemaitre et al. in 2001 have previously discussed that the level of activity displayed by PZAse mutants is correlated with the location of the substituted amino acids [5]. Those that are close to the catalytic site diminish the activity of the enzyme more than those that are far apart [5]. We found that this is not generally true. This study showed that the PZAse structure is a proximal predictor of PZAse function, confirming the well-known structure-function relationship. The lack of a high association between the PZAse structure and PZA-resistance level suggests that an important amount of PZA-resistance is determined by other factors than PZAse structure/function.

Conclusion

Our results showed that the PZAse structure was able to explain a high variability of the enzymatic function, but in a lesser extent the PZA-resistance level in M. tuberculosis. The PZAse structural aspects that best explained the variability of the enzymatic activity were those associated to the physicalchemical characteristics of the AS and the MCS. Despite the small number of mutations analyzed, our results confirm that the PZAse structure is a proximal predictor of PZAse function, confirming the well-known structure-function relationship. The lack of an important association between the PZAse structure and the PZA-resistance level suggests that an important amount of PZAresistance is determined by other factors than PZAse activity.

Funding

This research was partially funded by the National Institute of Allergy and Infectious Diseases, National Institutes of Health US, under the terms of Award No # 1R01 TW008669-01 and 1R03 AI067608-0. M. Zimic and P. Sheen received support from TMRC New Tools to Understand and Control Endemic Parasites # 1 P01 AI51976.
  16 in total

1.  GROMACS: fast, flexible, and free.

Authors:  David Van Der Spoel; Erik Lindahl; Berk Hess; Gerrit Groenhof; Alan E Mark; Herman J C Berendsen
Journal:  J Comput Chem       Date:  2005-12       Impact factor: 3.376

2.  AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR.

Authors:  R A Laskowski; J A Rullmannn; M W MacArthur; R Kaptein; J M Thornton
Journal:  J Biomol NMR       Date:  1996-12       Impact factor: 2.835

3.  Pyrazinamide sterilizing activity in vitro against semidormant Mycobacterium tuberculosis bacterial populations.

Authors:  L Heifets; P Lindholm-Levy
Journal:  Am Rev Respir Dis       Date:  1992-05

4.  Characterization of new mutations in pyrazinamide-resistant strains of Mycobacterium tuberculosis and identification of conserved regions important for the catalytic activity of the pyrazinamidase PncA.

Authors:  N Lemaitre; W Sougakoff; C Truffot-Pernot; V Jarlier
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

5.  Study of the structure-activity relationships for the pyrazinamidase (PncA) from Mycobacterium tuberculosis.

Authors:  N Lemaitre; I Callebaut; F Frenois; V Jarlier; W Sougakoff
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

6.  Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Turkey.

Authors:  Pelin Yüksel; Ozlem Tansel
Journal:  New Microbiol       Date:  2009-04       Impact factor: 2.479

Review 7.  Mechanisms of drug resistance in Mycobacterium tuberculosis.

Authors:  Mary Margaret Wade; Ying Zhang
Journal:  Front Biosci       Date:  2004-01-01

8.  Effect of pyrazinamidase activity on pyrazinamide resistance in Mycobacterium tuberculosis.

Authors:  Patricia Sheen; Patricia Ferrer; Robert H Gilman; Jon López-Llano; Patricia Fuentes; Eddy Valencia; Mirko J Zimic
Journal:  Tuberculosis (Edinb)       Date:  2009-02-26       Impact factor: 3.131

9.  Dynamics of antibiotic resistant Mycobacterium tuberculosis during long-term infection and antibiotic treatment.

Authors:  Solomon H Mariam; Jim Werngren; Joakim Aronsson; Sven Hoffner; Dan I Andersson
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

Review 10.  Homology modelling and spectroscopy, a never-ending love story.

Authors:  Hanka Venselaar; Robbie P Joosten; Bas Vroling; Coos A B Baakman; Maarten L Hekkelman; Elmar Krieger; Gert Vriend
Journal:  Eur Biophys J       Date:  2009-08-29       Impact factor: 1.733

View more
  7 in total

1.  Role of metal ions on the activity of Mycobacterium tuberculosis pyrazinamidase.

Authors:  Patricia Sheen; Patricia Ferrer; Robert H Gilman; Gina Christiansen; Paola Moreno-Román; Andrés H Gutiérrez; Jun Sotelo; Wilfredo Evangelista; Patricia Fuentes; Daniel Rueda; Myra Flores; Paula Olivera; José Solis; Alessandro Pesaresi; Doriano Lamba; Mirko Zimic
Journal:  Am J Trop Med Hyg       Date:  2012-07       Impact factor: 2.345

2.  Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates from Korea and analysis of the correlation between the mutations and pyrazinamidase activity.

Authors:  Jee-Hyun Yoon; Ji-Sun Nam; Kyung-Jin Kim; Young-Tae Ro
Journal:  World J Microbiol Biotechnol       Date:  2014-07-18       Impact factor: 3.312

3.  Evaluation of methods for testing the susceptibility of clinical Mycobacterium tuberculosis isolates to pyrazinamide.

Authors:  Zhenling Cui; Jie Wang; Junmei Lu; Xiaochen Huang; Ruijuan Zheng; Zhongyi Hu
Journal:  J Clin Microbiol       Date:  2013-02-06       Impact factor: 5.948

4.  Mechanistic analysis elucidating the relationship between Lys96 mutation in Mycobacterium tuberculosis pyrazinamidase enzyme and pyrazinamide susceptibility.

Authors:  Chakshu Vats; Jaspreet Dhanjal; Sukriti Goyal; Ankita Gupta; Navneeta Bharadvaja; Abhinav Grover
Journal:  BMC Genomics       Date:  2015-01-21       Impact factor: 3.969

5.  Prediction of Mycobacterium tuberculosis pyrazinamidase function based on structural stability, physicochemical and geometrical descriptors.

Authors:  Rydberg Roman Supo-Escalante; Aldhair Médico; Eduardo Gushiken; Gustavo E Olivos-Ramírez; Yaneth Quispe; Fiorella Torres; Melissa Zamudio; Ricardo Antiparra; L Mario Amzel; Robert H Gilman; Patricia Sheen; Mirko Zimic
Journal:  PLoS One       Date:  2020-07-31       Impact factor: 3.240

6.  Metallochaperones Are Needed for Mycobacterium tuberculosis and Escherichia coli Nicotinamidase-Pyrazinamidase Activity.

Authors:  Patricia Sheen; Anuntxi Monsalve; Jhanina Campos; Rodolfo Huerta; Ricardo Antiparra; Héctor Arteaga; Patricia Duran; Carlos Bueno; Daniela E Kirwan; Robert H Gilman; Mirko Zimic
Journal:  J Bacteriol       Date:  2020-01-02       Impact factor: 3.490

7.  Nicotinamidase/pyrazinamidase of Mycobacterium tuberculosis forms homo-dimers stabilized by disulfide bonds.

Authors:  Daniel Rueda; Patricia Sheen; Robert H Gilman; Carlos Bueno; Marco Santos; Victoria Pando-Robles; Cesar V Batista; Mirko Zimic
Journal:  Tuberculosis (Edinb)       Date:  2014-08-24       Impact factor: 3.131

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.